2[23]O'Connor OA,Wright J,Moskowitz C,et al.Phase Ⅱ clinical experience with the nover proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma.J Clin Oncol.2005,23 (4):676
3[24]Stupp R,Mason WP,van den Bent MJ. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.N En gl J Med,2005,352:987
4[25]Oeffinger KC,Mertens AC,Sklar CA,et al.Prevalence and severity of chronic diseases in adult survivors of childhood cancer:Areport from the Childhood Cancer Survivor Study.2005ASCO Annual Meeting,Abstract NO:9
5[1]Winton T,Livingston R,Johnson D,et al.Vinorelbine plus cisplatin vs observation in resected non-small-cell lung cancer.N Engl J Med,2005,352 (25):2589
6[2]Douillard J,Rosell R,Delena M,et al.ANITA:Phase Ⅲ adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely rescted (Stage-Ⅲ) non-small-cell lung cancer (NSCLC) patients (pts):Final results after 70-month median follow-up.On behalf of the Adjuvant Navelbine International Trialist Association.2005 ASCO Annual Meeting,Abstract NO:7019
7[3]Strauss GM,Herndon J,Maddaus MA,et al.Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carbo plation following resection in Stage IB non-small cell lung cancer (NSCLC):Report of Cancer and Leukemia Group (CALGB) Protocol 9633.2004 ASCO Annual Meeting.Abstract NO:7019
8[4]Piccart-Gebhart MJ,Procter M,Leyland-Jones B,et al.Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.N Engl J Med,2005,353 (16) :1659
9[5]Gramont de A,Boin C,Navarro M,et al.Oxaliplatin/SFU/LV in the adjuvant treatment of stage Ⅱ and stage Ⅲ colon cancer:Efficacy results with a median follow-up of 4 years.2005 asco Annual Meeting.Abstract NO:3501
10[6]Wolmark N,Wieand S,Kuebler JP,et al.A phase Ⅲ trial comparing FULV to FULV + oxaliplatin in stage Ⅱ of Ⅲ carcino ma of the colon:Results of NSABP Protocol C-0Sub-category:Colorectal Cancer (including live metastases).2005 ASCO Annual Meeting,Abstract NO:3500
